Cite
HARVARD Citation
Pugliese, D. et al. (2022). Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study. Alimentary pharmacology & therapeutics. 56 (1), pp. 95-109. [Online].